ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.000
+0.008 (0.81%)
Nov 3, 2026, 5:29 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 23.75 million as of November 3, 2026. It is the 47,406th most valuable company in the world and the 741st biggest in Sweden. Its market cap has decreased by 60.24% in one year.
Market Cap
23.75M
Enterprise Value
-9.18M
Revenue
24.25M
Global Rank
Country Rank
#741 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 23.75M, a decrease of -79.82%. That is a compound annual growth rate of -14.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 23.75M | -57.69% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 77.45M |
| Pila Pharma AB | 71.26M |
| AcouSort AB | 68.15M |
| Annexin Pharmaceuticals AB | 57.89M |
| Nanologica AB | 54.25M |
| Fluicell AB | 38.33M |
| Spago Nanomedical AB | 32.09M |
| NextCell Pharma AB | 29.07M |